Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ymgme.2020.10.002 http://scihub22266oqcxt.onion/10.1016/j.ymgme.2020.10.002 33129691!7537630!33129691     free     free     free       Mol+Genet+Metab 2020 ; 131 (1-2): 1-13 Nephropedia Template TP {{tp|p=33129691|t=2020. Clinical trials in mitochondrial disorders, an update |pdf=|usr=}}{{33129691}} gab.com Text Clinical trials in mitochondrial disorders, an update JO: Mol Genet Metab http://www.kidney.de/pget.php?&tw=1&pmid=33129691 #FOAvip Mitochondrial disorders comprise a molecular and clinically diverse group of diseases that are associated with mitochondrial dysfunction leading to multi-organ disease. With recent advances in molecular technologies, the understanding of the pathomechanisms of a growing list of mitochondrial disorders has been greatly expanded. However, the therapeutic approaches for mitochondrial disorders have lagged behind with treatment options limited mainly to symptom specific therapies and supportive measures. There is an increasing number of clinical trials in mitochondrial disorders aiming for more specific and effective therapies. This review will cover different treatment modalities currently used in mitochondrial disorders, focusing on recent and ongoing clinical trials. Twit Text FOAVip Clinical trials in mitochondrial disorders, an update ????Mol Genet Metab http://www.kidney.de/pget.php?&tw=1&pmid=33129691 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33129691 #FOAvip English Wikipedia <ref>{{Cite pmid|33129691}}</ref> Clinical trials in mitochondrial disorders, an update #MMPMID33129691 Almannai M; El-Hattab AW; Ali M; Soler-Alfonso C; Scaglia F Mol Genet Metab 2020[Sep]; 131 (1-2): 1-13 PMID33129691show ga Mitochondrial disorders comprise a molecular and clinically diverse group of diseases that are associated with mitochondrial dysfunction leading to multi-organ disease. With recent advances in molecular technologies, the understanding of the pathomechanisms of a growing list of mitochondrial disorders has been greatly expanded. However, the therapeutic approaches for mitochondrial disorders have lagged behind with treatment options limited mainly to symptom specific therapies and supportive measures. There is an increasing number of clinical trials in mitochondrial disorders aiming for more specific and effective therapies. This review will cover different treatment modalities currently used in mitochondrial disorders, focusing on recent and ongoing clinical trials. |*Clinical Trials as Topic[MESH] |*Genetic Therapy[MESH] |Antioxidants/therapeutic use[MESH] |DNA, Mitochondrial/genetics[MESH] |Humans[MESH] |Mitochondria/drug effects/*genetics/metabolism/pathology[MESH]Clinical trials in mitochondrial disorders, an update (epmc).pdf DeepDyve Pubget Overpricing